Exploitation of dt40 cells to study the mechanism of immunoglobulin gene diversification

Projektinformationen

SILVESTRO CONTICELLO

ID Finanzhilfevereinbarung: HPMF-CT-2002-02085

Projekt abgeschlossen

Startdatum 1 Oktober 2002

Enddatum 30 September 2004

Finanziert unter

• Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Gesamtkosten € 114 272,00

EU-Beitrag € 114 272,00

Koordiniert durch

MEDICAL RESEARCH COUNCIL
United Kingdom

Ziel

We will use the DT40 cell line to investigate the role of immunoglobulin specific transcription factors in targeting of hyper mutation, the mechanism of action of AID in controlling the process and the possible involvement of error prone polymerases.

Wissenschaftliches Gebiet

• natural sciences › biological sciences › genetics › mutation

Programm/Programme

• FP5-HUMAN POTENTIAL - Programme for research, technological development and demonstration on "Improving the human research potential and the socio-economic knowledge base" (1998-2002)

Thema/Themen

Data not available

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

MEDICAL RESEARCH COUNCIL

• EU-Beitrag: Keine Daten
• Adresse: Hills Road ; CB2 2QH CAMBRIDGE ; Vereinigtes Königreich
• Gesamtkosten: Keine Daten